Drugs / Bolgre
Bolgre
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00802139 Comparator | Feb 2008 → Jun 2009 | iron deficiency anemia | JW Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bolgre | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00802139 ↗ |
| Known as | Iron acetyl-transferase | “Bolgre (Iron acetyl-transferase)” NCT00802139 ↗ |
| Known as | Iron Acetyl-transferrin Hydroglycerin | “Oral Iron Acetyl-transferrin Hydroglycerin (Bolgre®)” NCT00802139 ↗ |
| Route | Oral | “Oral Iron Acetyl-transferrin Hydroglycerin (Bolgre®)” NCT00802139 ↗ |